Children and Adolescents With Moderate-to-severe Atopic Dermatitis Clinical Trials in Shenyang, Liaoning

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis